We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
English Biomedicine Reproductive medicine

Search Results

Showing 1-20 of 1,274 results

  1. Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality

    Background

    To assess cancer-specific mortality (CSM) and other-cause mortality (OCM) rates in patients with rare histological prostate cancer subtypes.

    ...
    Carolin Siech, Mario de Angelis, ... Pierre I. Karakiewicz in Prostate Cancer and Prostatic Diseases
    Article Open access 10 July 2024

  2. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms

    Background

    Prostatic inflammation is an important etiological component of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)....

    Stavros Gravas, Cosimo De Nunzio, ... Mauro Gacci in Prostate Cancer and Prostatic Diseases
    Article Open access 06 July 2024

  4. Impact of a rash management guide in patients receiving apalutamide for high-risk localized prostate cancer in the Apa-RP study

    Background/objectives

    Based on the SPARTAN and TITAN studies, apalutamide is approved for patients with nonmetastatic castration-resistant and...

    Neal Shore, Jason Hafron, ... Tracy McGowan in Prostate Cancer and Prostatic Diseases
    Article Open access 05 July 2024

  5. Should systematic prostatic biopsies be discontinued?

    Introduction

    The use of systematic biopsies in addition to targeted biopsies is based on multiple studies showing that 15–20% of “clinically...

    Laurence Klotz in Prostate Cancer and Prostatic Diseases
    Article 27 June 2024

  6. ChatGPT can help guide and empower patients after prostate cancer diagnosis

    Background/Objectives

    Patients often face uncertainty about what they should know after prostate cancer diagnosis. Web-based information is common but...

    Harry Collin, Kandice Keogh, ... Matthew J. Roberts in Prostate Cancer and Prostatic Diseases
    Article Open access 26 June 2024

  7. Sexual outcomes in men who have sex with men who underwent radical prostatectomy

    Background

    Sexual difficulties are a recognized consequence of prostate cancer (PCa) treatments. An estimated one in three men who have sex with men...

    F. Vedovo, C. Lonati, ... C. Trombetta in Prostate Cancer and Prostatic Diseases
    Article 25 June 2024

  10. The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer

    Background

    The onset of castration-resistance is associated with dismal outcomes in patients with prostate cancer (PCa). Metastasis directed therapy...

    Jennifer Le Guevelou, Francesco Cuccia, ... David Pasquier in Prostate Cancer and Prostatic Diseases
    Article 19 June 2024

  11. Fatty acid diet and prostate cancer: a treasure hunt or a wild goose chase?

    Georges Mjaess, Thierry Roumeguère, ... Karim Zouaoui Boudjeltia in Prostate Cancer and Prostatic Diseases
    Article 18 June 2024

  12. Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement?

    Background

    ChatGPT has recently emerged as a novel resource for patients’ disease-specific inquiries. There is, however, limited evidence assessing...

    Angie K. Puerto Nino, Valentina Garcia Perez, ... Dean S. Elterman in Prostate Cancer and Prostatic Diseases
    Article Open access 13 June 2024

  14. Re: Influence of anterior fibromuscular stroma on incontinence outcomes in RASP and HoLEP

    Antonio Andrea Grosso, Daniele Amparore, ... Andrea Minervini in Prostate Cancer and Prostatic Diseases
    Article 11 June 2024

  15. Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience

    Objectives

    To evaluate the long-term oncological outcomes and functional results of the neurovascular structure-adjacent frozen-section examination...

    Francesca Ambrosini, Felix Preisser, ... Alexander Haese in Prostate Cancer and Prostatic Diseases
    Article 11 June 2024

  16. Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era

    Background

    Multiparametric prostate MRI (mpMRI) is being increasingly adopted for work-up of prostate cancer. For patients selected to omit biopsy, we...

    Eric V. Li, Anna M. Busza, ... Ashley E. Ross in Prostate Cancer and Prostatic Diseases
    Article 10 June 2024

  17. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer

    Background

    Recognizing the limitations of prostate-specific antigen (PSA) screening and the morbidity of prostate biopsies, several blood- and...

    Hunter S. Robinson, Sangmyung S. Lee, ... Jeffrey J. Tosoian in Prostate Cancer and Prostatic Diseases
    Article 10 June 2024

  18. Risk calculators for the detection of prostate cancer: a systematic review

    Background

    Prostate cancer (PCa) (early) detection poses significant challenges, including unnecessary testing and the risk of potential...

    Frederique B. Denijs, Meike J. van Harten, ... Monique J. Roobol in Prostate Cancer and Prostatic Diseases
    Article 03 June 2024

  19. A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer

    Background

    Positron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) is notable for its superior...

    Andrea Mari, Anna Cadenar, ... Andrea Minervini in Prostate Cancer and Prostatic Diseases
    Article 31 May 2024
Did you find what you were looking for? Share feedback.